Search

Author/Creator San-Miguel, Jesus F

1. Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study. Issue 1 (January 2021)

Authors:
Laubach, Jacob P; Schjesvold, Fredrik; Mariz, Mário; Dimopoulos, Meletios A; Lech-Maranda, Ewa; Spicka, Ivan; Hungria, Vania T M; Shelekhova, Tatiana; Abdo, Andre; Jacobasch, Lutz; Polprasert, Chantana; Hájek, Roman; Illés, Árpád; Wróbel, Tomasz; Sureda, Anna; Beksac, Meral; Gonçalves, Iara Z; Bl...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study. Issue 10301 (21st August 2021)

Authors:
Usmani, Saad Z; Garfall, Alfred L; van de Donk, Niels W C J; Nahi, Hareth; San-Miguel, Jesus F; Oriol, Albert; Rosinol, Laura; Chari, Ajai; Bhutani, Manisha; Karlin, Lionel; Benboubker, Lotfi; Pei, Lixia; Verona, Raluca; Girgis, Suzette; Stephenson, Tara; Elsayed, Yusri; Infante, Jeffrey; Goldber...
Journal:
Lancet
Issue:
Volume 398:Issue 10301(2021)
Page Start:
665
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search